Cihan Atila, M.D., principal investigator Department of Endocrinology, Diabetology and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland, reports that now, for the first time, researchers from the University of Basel and the University
Well, it looks like Diabetes Insipidus is on the way out, at least from the naming point of view. After the work done in Basel (Universitätsspital Basel), recently published in The Lancet, an international consensus group proposed a name change from Diabetes Insipidus to Arginine Vasopressin Deficiency or AVP-D, or Arginine Vasopressin Resistance or AVP-R, depending on the type.
We want your thoughts and opinions on our LIVE-TALK program, your preferences for times and days, other subjects we should cover, and any other issues you’d like us to consider to ensure the program reflects your insights.
COR2ED is an independent medical education company based in Europe. They have partnered with a scientific committee comprising endocrinologists, nurses, and patient advocacy groups (WAPO and INCA) to develop two surveys to explore the injection
An opinion editorial from J D Faccinetti, co-founder, on listening and interpreting without influencing – Progressive, innovative enterprises have been putting the voice of the consumer front and center in product and communications development since
Has COVID-19 affected you or not? What narrative will you construct as time moves forward resulting from the events of recent years? Pausing to examine what you choose to derive is up to each person, but it is essential to know that the more a person decides to choose rather than allow the choice to be made for them, the more they can move forward and beyond. Having lived through a worldwide pandemic means we have all not only survived, but we’ve endured.
Help us increase the medical field’s knowledge of CDI by participating in this short five-minute anonymous survey. An international team of researchers will collect the patient data to help physicians and patients understand how to manage DI
From Linda M. Rio, MA, Marriage and Family Therapist – I have written for PWN in previous articles on the impact of pituitary disease on the family and more recently on the importance of family and
Join our LIVE roundtable discussion on mental and emotional health Friday, July 9th, 2021, 9:00 am PST. Click here for more information and registration. There is no charge! By Erin Sesemann, Ph.D., LMFT, CBIS –
Pituitary World News has undertaken an initiative to understand and share the complicated issues related to access to medications and costs so pituitary patients can join us in advocating for better healthcare systems. In that mesh of confusion, we find insurance companies, orphan drug manufacturers, specialty pharmacies, pharmacy benefit managers, also known as PBM’s, prescribers, and others that add to the costs and complicate access. The issues get even murkier when considering patients on Medicare, Medicaid, pricing models, and copay requirements.
Acromegaly patients and healthcare providers worldwide can participate in this survey and provide updated information that may help improve quality of life during the COVID-19 pandemic. Much of this initiative’s success will depend on your